Historical record - last NADAC effective date: 7/17/2024
Product Information
GABAPENTIN 100 MG CAPSULE is a generic product labeled by Strides Pharma Inc., priced at $0.0233 per EA under NDC 64380086707. Its NADAC has been published 175 times since Aug 5, 2020.
FDA first approved this application on Oct 16, 2018. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
100 mg/1
Manufacturer
Strides Pharma Inc.NDC
64380086707
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
7/17/2024
Active Ingredients
GABAPENTINApproval Type
Generic (ANDA)
FDA Application
ANDA211314FDA Approved
10/16/2018
TE Code
AB
On Market Since
10/17/2018
Pharmacological Classes
Price Statistics
The NADAC for GABAPENTIN 100 MG CAPSULE has been published 175 times since Aug 5, 2020, and over the history we have for it it has declined 34.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0233 per EA |
|---|---|
| All-time high | $0.0357 (Aug 12, 2020) |
| All-time low | $0.0232 (Apr 17, 2024) |
| Median price | $0.0291 |
| Average price | $0.0289 |
| Largest weekly change | -11.7% (Apr 17, 2024) |
| Weeks tracked | 175 |
| Tracking since | Aug 5, 2020 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
-9.8%
5Y
-24.5%
All
-34.6%
Last surveyed Jul 31, 2024 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 8 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 10% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of GABAPENTIN 100 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for GABAPENTIN 100 MG CAPSULE, manufactured by Strides Pharma Inc., is $0.0233 per EA (NDC 64380086707), effective Jul 31, 2024.
How has the price of GABAPENTIN 100 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for GABAPENTIN 100 MG CAPSULE has declined 34.6%. It has been tracked across 175 weekly CMS publications since Aug 5, 2020.
What are the highest and lowest recorded NADAC prices for GABAPENTIN 100 MG CAPSULE?
Since Aug 5, 2020, the NADAC for GABAPENTIN 100 MG CAPSULE has ranged from a low of $0.0232 (Apr 17, 2024) to a high of $0.0357 (Aug 12, 2020), with a median of $0.0291 per EA.
Are there cheaper alternatives to GABAPENTIN 100 MG CAPSULE?
Yes. 8 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, GABAPENTIN 100 MG CAPSULE, is $0.0209 per EA — about 10% below GABAPENTIN 100 MG CAPSULE.
Who manufactures GABAPENTIN 100 MG CAPSULE?
GABAPENTIN 100 MG CAPSULE (NDC 64380086707) is labeled by Strides Pharma Inc., and CMS classifies it as a generic product.